Avantor, Inc. (AVTR) — closed signal from July 1, 2025
Partial Published before the outcome was known, scored automatically when the window closed on September 29, 2025.
Predicted vs. what happened
What happened
Reached 13% of the predicted growth at its peak, without hitting the target.
The thesis — published July 1, 2025
Shares fell because sales came in lower than hoped, but energy in the stock is now very strong and lots more people are buying than usual. Wall Street firm Jefferies still says the shares could reach $20. The company talks to investors on 1 Aug, and because expectations are low, even a small improvement could impress. Cost cutting and easier comparisons could spark about a 20% bounce within three months, giving a clear near-term opportunity.
Primary drivers
- Very strong price energy and heavy buying hint the downtrend has turned up.
- Jefferies still says shares can reach $20, showing big investors remain confident.
- Upcoming 1 Aug results are expected to be modest, so any good news could lift the stock quickly.
- Money is moving into lab-supply companies, bringing in more buyers for the shares.
How it played out
AVTR: target was not reached
Lyra published AVTR on 2025-07-01 at 14.02. The thesis expected 22% growth toward 17.10 over a short-term window. It pointed to very strong price energy, heavy buying, a Jefferies view that shares could reach $20, modest expectations for the 1 Aug results, cost cutting, easier comparisons, and money moving into lab-supply companies.
Inside the window from 2025-07-01 to 2025-09-29, AVTR peaked at 14.42 on 2025-07-01, a 2.9% gain. That stayed below the 17.10 target. It never got there. The stock ended the window at 11.84, so the thesis missed.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.